RMTI RMTI

Q: What is the current share price of RMTI?

As of 2026-08-05 17:25 PDT, RMTI trades at $7.26 on NASDAQ/NYSE. Its 52-week range is $5.19 to $18.30.

Q: What is the market capitalisation of RMTI?

RMTI has a market capitalisation of $28.61M on NASDAQ/NYSE.

Q: What is the P/E ratio of RMTI?

RMTI trades at a trailing price-to-earnings (P/E) ratio of -4.84. Its price-to-book (P/B) ratio is 0.77.

Q: What is the return on equity (ROE) of RMTI?

RMTI has a return on equity (ROE) of -14.37%. Its return on capital employed (ROCE) is -9.86%.

Q: Is RMTI a good stock to buy?

This page provides a data-driven analysis of RMTI, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Company Profile ↓

$7.26

-24.38% 1Y

Mkt Cap$28.61M

P/E-4.84

P/B0.77

52W High$18.30

52W Low$5.19

Book Value$9.38

EPS (TTM)$-1.50

Company Overview

RMTI (RMTI) is a publicly traded company listed on with a market capitalization of $28.61M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.

Why Investors Should Care

Conservative Balance Sheet

Carries low leverage with a debt-to-equity ratio of 0.34.

Recent Developments

Dec 2025 Revenue of $69.26M (-31.8% YoY); net profit $-5.31M.
Trailing 12 Months Year-on-year growth — revenue -31.8%.
5-Year Trend Long-term compounding — revenue CAGR 1.5%.

Growth & Price Performance

Compounded Sales Growth

5 Years:	1.48%
1 Year:	-31.76%

Stock Price Performance

1 Year:	-24.38%
6 Months:	-35.18%
3 Months:	-15.58%
1 Month:	+19.02%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Mixed

52-Week Range 16% of range

$5.19 $18.30

Trend Signals

Price vs 50-DMAAbove
Price vs 200-DMABelow
RSI (14)62.28 · Neutral

Price Performance

1M+19.02%

3M-15.58%

6M-35.18%

1Y-24.38%

Auto-generated from price history and fundamentals; not investment advice.

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Period: Metric:

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

No notable strengths flagged.

CONS

Trading 60.3% below its 52-week high.
In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

Valuation

Stock P/E

-4.84

Industry PE

Forward P/E

PEG Ratio

Book Value

$9.38

Price to Book

0.77

P/S

EV/EBITDA

Dividend Yield

0.00%

Growth (CAGR)

Revenue 5Y

1.48%

Profit 5Y

Revenue (YoY)

-31.76%

Earnings (YoY)

Profitability & Returns

ROCE

-9.86%

ROE

-14.37%

ROA

-9.30%

Profit Margin

-7.67%

Op Margin

-6.77%

Gross Margin

16.89%

EPS (Latest Qtr)

$-0.40

EPS (TTM)

$-1.50

Balance Sheet & Liquidity

Debt/Equity

0.34

Quick Ratio

3.63

Current Ratio

3.98

Debt

$12.47M

Total Assets

$57.42M

Current Assets

$36.94M

Working Capital

$28.58M

Ownership

Promoter Holding

15.12%

Chg in Prom Hold

FII / Inst Holding

9.87%

Chg in FII Hold

Financial Snapshot

Enterprise Value

Total Revenue (TTM)

$69.26M

EBITDA

$-2.00M

Free Cash Flow

$-1.20M

Operating Cash Flow

$-659.00K

Shares Outstanding

3.94M

Gross Margin

16.89%

Payout Ratio

Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric	Dec 2014	Mar 2015	Jun 2015	Sep 2015	Dec 2015	Mar 2016	Jun 2016	Sep 2016	Dec 2016	Mar 2017	Jun 2017	Sep 2017	Dec 2017	Mar 2018	Jun 2018	Sep 2018	Mar 2019	Jun 2019	Sep 2019	Mar 2020	Jun 2020	Sep 2020	Mar 2021	Jun 2021	Sep 2021	Mar 2022	Jun 2022	Sep 2022	Mar 2023	Jun 2023	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	-	-	-	-	-	-	-	-	-	14.59M	13.24M	14.63M	-	14.95M	14.91M	16.67M	15.56M	14.85M	15.41M	15.86M	15.90M	15.28M	15.47M	15.14M	15.99M	16.12M	18.68M	18.69M	19.67M	18.08M	23.77M	22.68M	25.83M	28.32M	-	18.91M	16.07M	15.93M	18.35M	17.34M
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	15.87M	13.57M	13.65M	14.47M	14.44M
Gross Profit	2.58M	2.31M	2.07M	2.50M	2.06M	1.69M	1.49M	1.58M	1.99M	2.36M	1.50M	1.07M	-1.22M	-720.49K	-4.02M	1.97M	1.01M	733.15K	-17.00K	1.11M	881.00K	346.00K	401.00K	-262.00K	-329.00K	-786.00K	1.75M	777.00K	2.60M	1.03M	2.20M	3.06M	4.55M	6.24M	-	3.04M	2.50M	2.27M	3.88M	2.90M
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4.40M	3.85M	3.86M	4.28M	4.38M
Operating Income	-5.02M	-3.81M	-2.65M	-2.57M	-6.06M	-4.61M	-5.59M	-4.75M	-5.26M	-4.96M	-6.72M	-5.03M	-9.22M	-5.72M	-12.30M	-5.00M	-8.81M	-10.37M	-7.94M	-8.05M	-5.60M	-6.69M	-7.18M	-7.82M	-6.97M	-6.63M	-4.48M	-3.71M	-1.43M	-2.96M	-1.74M	-1.32M	515.00K	1.94M	-	-1.36M	-1.35M	-1.58M	-398.00K	-1.48M
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-699.00K	-653.00K	-924.00K	278.00K	-812.00K
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	277.00K	276.00K	285.00K	286.00K	282.00K
Pretax Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1.51M	-1.49M	-1.75M	-554.00K	-1.60M
Tax Provision	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-6.38M	-3.70M	-2.54M	-2.41M	-5.77M	-4.82M	-5.36M	-4.56M	-5.05M	-4.74M	-7.08M	-5.06M	-9.04M	-5.55M	-12.23M	-4.97M	-8.68M	-10.29M	-7.86M	-7.98M	-6.89M	-7.35M	-7.75M	-8.40M	-7.58M	-7.16M	-4.97M	-4.19M	-1.75M	-3.31M	-1.87M	-1.73M	343.00K	1.66M	-	-1.51M	-1.49M	-1.75M	-554.00K	-1.60M
Diluted EPS	-	-0.07	-0.05	-0.05	-	-0.10	-0.11	-0.09	-	-0.09	-0.14	-0.10	-	-0.13	-	-	-	-	-	-0.12	-0.10	-0.10	-0.91	-0.99	-0.89	-0.84	-0.43	-0.23	-0.10	-0.18	-0.07	-0.06	0.01	0.04	-	-0.40	-0.50	-0.50	-0.10	-0.40
R&D Expense	1.68M	799.59K	885.26K	1.25M	2.03M	1.31M	2.06M	1.26M	1.20M	1.21M	1.68M	1.30M	2.13M	1.67M	1.56M	808.19K	497.28K	2.96M	1.48M	1.82M	1.62M	1.75M	1.81M	2.42M	1.22M	1.57M	926.00K	469.00K	278.00K	167.00K	494.00K	18.00K	0	0	-	0	0	0	-	-

Profit & Loss (Annual)

Figures in USD.

Metric	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Revenue	54.73M	59.55M	48.97M	49.84M	52.38M	54.19M	55.35M	53.28M	57.30M	63.39M	61.30M	62.20M	61.93M	72.81M	83.61M	101.49M	69.26M
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	68.73M	74.91M	84.00M	57.56M
Gross Profit	7.89M	9.86M	5.64M	6.69M	6.66M	8.55M	8.94M	6.75M	3.70M	-1.58M	2.84M	2.73M	-2.42M	4.08M	8.70M	17.48M	11.70M
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	20.86M	15.37M	16.88M	16.39M
Operating Income	-5.48M	-2.87M	-21.68M	-54.26M	-47.06M	-17.56M	-15.10M	-20.21M	-25.92M	-32.44M	-34.52M	-28.42M	-30.34M	-16.78M	-6.67M	608.00K	-4.69M
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-16.17M	-4.69M	2.95M	-2.00M
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	1.94M	2.30M	1.25M	1.12M
Pretax Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-18.68M	-8.44M	-480.00K	-5.31M
Tax Provision	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-5.50M	-2.68M	-21.44M	-54.02M	-48.78M	-21.33M	-14.42M	-19.80M	-25.92M	-32.13M	-34.13M	-30.89M	-32.67M	-18.68M	-8.44M	-480.00K	-5.31M
Diluted EPS	-	-	-	-	-	-0.52	-0.29	-0.39	-0.51	-	-	-0.41	-3.83	-18.90	-3.70	-0.30	-1.50
R&D Expense	6.45M	3.42M	17.81M	48.27M	39.38M	7.78M	4.96M	5.84M	6.32M	5.64M	-	-	-	-	1.11M	19.00K	0

Balance Sheet (Annual)

Figures in USD.

Metric	Dec 2008	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Assets	-	-	36.97M	31.94M	17.03M	36.36M	98.00M	87.82M	83.15M	58.78M	52.56M	44.32M	77.75M	-	46.63M	52.17M	59.21M	57.15M
Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	35.31M	28.77M	37.03M	38.16M
Cash & Equivalents	5.60M	23.04M	12.26M	5.72M	4.71M	11.88M	65.80M	31.20M	17.18M	8.41M	22.71M	11.79M	48.68M	-	10.10M	8.98M	15.66M	10.71M
Inventory	-	-	-	-	-	-	-	-	-	-	-	-	-	-	5.81M	5.87M	5.78M	3.42M
Receivables	-	-	-	-	-	-	-	-	-	-	-	-	-	-	6.26M	10.90M	8.29M	8.14M
Total Liabilities	-	-	-	-	-	-	-	-	-	25.87M	25.28M	24.00M	43.58M	-	32.53M	30.88M	26.62M	20.16M
Current Liabilities	-	-	6.42M	13.69M	26.99M	17.85M	9.80M	8.09M	10.15M	9.14M	13.20M	12.37M	12.79M	-	17.69M	16.64M	14.09M	9.58M
Long Term Debt	-	-	-	-	-	17.92M	-	-	-	-	-	0	20.95M	-	7.55M	8.29M	8.47M	8.83M
Total Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	16.36M	13.44M	13.54M	12.47M
Total Equity	11.82M	29.32M	30.54M	18.24M	-9.96M	595.54K	68.70M	62.32M	52.96M	32.91M	27.28M	20.32M	34.17M	-	14.11M	21.29M	32.59M	36.98M
Shares Outstanding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.22M	2.91M	3.41M	3.94M

Cash Flows (Annual)

Figures in USD.

Metric	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Operating Cash Flow	-1.43M	2.10M	-10.78M	-30.75M	-50.66M	4.26M	-13.33M	-12.45M	-21.11M	-20.42M	-27.25M	-29.64M	-	-16.93M	-9.41M	4.20M	-659.00K
Investing Cash Flow	-1.60M	-12.92M	-587.93K	11.52M	-12.65M	-8.81M	-21.14M	-1.64M	14.50M	12.72M	-4.75M	3.21M	-	-2.40M	-3.04M	-4.87M	-8.54M
Financing Cash Flow	20.47M	46.73K	4.82M	18.22M	70.48M	58.47M	-132.67K	80.16K	-2.16M	22.00M	21.09M	63.32M	-	16.15M	11.34M	7.35M	4.25M
Capital Expenditure	-	-	-	-	-	-	-	-	-	-	-	-	-	-281.00K	-284.00K	-1.01M	-542.00K
Free Cash Flow	-	-	-	-	-	-	-	-	-	-	-	-	-	-17.21M	-9.70M	3.19M	-1.20M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-	-	-	-	-3.17M	-1.11M	6.68M	-4.95M

Ratios (Annual)

Figures in %.

Metric	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Gross Margin %	14.4%	16.6%	11.5%	13.4%	12.7%	15.8%	16.1%	12.7%	6.5%	-2.5%	4.6%	4.4%	-3.9%	5.6%	10.4%	17.2%	16.9%
Operating Margin %	-10.0%	-4.8%	-44.3%	-108.9%	-89.8%	-32.4%	-27.3%	-37.9%	-45.2%	-51.2%	-56.3%	-45.7%	-49.0%	-23.0%	-8.0%	0.6%	-6.8%
Net Margin %	-10.1%	-4.5%	-43.8%	-108.4%	-93.1%	-39.4%	-26.1%	-37.2%	-45.2%	-50.7%	-55.7%	-49.7%	-52.8%	-25.7%	-10.1%	-0.5%	-7.7%
ROE %	-18.8%	-8.8%	-117.5%	542.3%	-8,191.5%	-31.0%	-23.1%	-37.4%	-78.8%	-117.8%	-168.0%	-90.4%	-	-132.4%	-39.6%	-1.5%	-14.4%
ROCE %	-	-9.4%	-118.8%	544.7%	-254.2%	-19.9%	-18.9%	-27.7%	-52.2%	-82.4%	-108.1%	-43.8%	-	-58.0%	-18.8%	1.3%	-9.9%

Shareholding Pattern

Insiders

15.12%

Institutions

9.87%

Public Float

11.63%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for RMTI

Google News hu, 23 Jul 2026

Rockwell Medical, Inc. (RMTI) stock price, news, quote and history - Yahoo Finance Australia

<a href="https://news.google.com/rss/articles/CBMiUkFVX3lxTE5jYkdZUjJfdE9iY0V4b2dkajR3S1ZEWjVqYkdRQnp1MkJFQW5SSDB4eERXRF9JV18xY1FIalFTc2JxM0tzZEsyMmZkQjBNZU1CbFE?oc=5" target="_blank">Rockwell Medical, Inc. (RMTI) stock price, news, quote a…

Google News Mon, 20 Jul 2026

Rockwell Medical Shares Maintain $1 Bid, Nasdaq Matter Closed - Stock Titan

<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxNandvZzNSMmZudHJlU2tSbFJQMl82RnYwX1huZV9rMUt0TmJSc25nendVQVFHTjZTeHlGbE51ZnpiVFUzNEptSFJscGM2NlFmdXhWWngzVXg4RXlybVdjNWZueElSRHVhUFQ0VXdLOW9SWmpNZGc1WHg5b0pMQlFPYVZ4NUd1My1ZTkFkcD…

Google News Mon, 29 Jun 2026

Rockwell Medical Announces First Reverse Stock Split In 4 Years – Nasdaq Compliance In Focus As Shares Haven’t Traded Above $1 Since March - Stocktwits

<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxQNEJSYksyUzJ1Vm1FU1U0d1h5V1ZXeDk2Y2Uwc0tGNlN2bE5KRDdVVnE5SUhQSmJLbXpMdmswb3RiNWppMV9xUWtWODR0a3JNRWJLSlA2ZzM1RTVGVWRieXZvTTZYVFh5V2ZVRkhHbzQxOEN4VVFqNjVnLVRvemlQQjJQZUJnTUFLTGltNG…

Google News hu, 26 Mar 2026

ROCKWELL MEDICAL ($RMTI) Releases Q4 2025 Earnings - Quiver Quantitative

<a href="https://news.google.com/rss/articles/CBMikwFBVV95cUxOZ0x4d29ZUjBlVDFoa3RoTWlib2Y2TWJpTlFVdGw4X29XVVZkRExtTUd4YjZCS00zMERnUmE1a25PWktwYTFUMDhod29XRFl6c05ZTDduNzZvVTFiZ0dJT1RiazVKSmdQOGdNdkoxUlJ0RlNIejN3R3E4VWNLdFlTcHd4eTM0NHZQX3RwYk…

Google News Fri, 27 Mar 2026

Should Value Investors Buy Rockwell Medical (RMTI) Stock? - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxOdmdHRXdyYjZPWVZQZmJlUWNpTGNOMHU0RHhQMWpqajlJSzBOcHl6NFV3TVpkTUpSMzZad3VLSmFZQXJ2V2YtbzJCZkhmSGJ5OXBnSFQ3RVk5UHJPbFZETVJwZFVMY1lYWTR2ZW5BS19tdkQxbnI5eU43WWlvU0tVb1lFSEVEZ1U4dWthdT…

Google News Wed, 20 May 2026

What's Going On With Rockwell Medical Stock Wednesday? - Benzinga

<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxNYUFsbjlSbjNsckEzZm00SG52N0RwWURJclZzZ2d6T1dWU2ZzSkRRazBZeWhSZlJldGtlcGhhYi1IalpnZktLZVhpZmRpZnd0Y2Jxclp0Wkh2bkM4eXdmSWoxS0NtQlFPY2NMMzJNUldMUzVKYmNXM255Ri1CYTVKN2U2VmgxeVFKdm9lSW…

RMTI — Frequently Asked Questions

What is the current share price of RMTI?

As of 2026-08-05 17:25 PDT, RMTI trades at $7.26 on NASDAQ/NYSE. Its 52-week range is $5.19 to $18.30.

What is the market capitalisation of RMTI?

RMTI has a market capitalisation of $28.61M on NASDAQ/NYSE.

What is the P/E ratio of RMTI?

RMTI trades at a trailing price-to-earnings (P/E) ratio of -4.84. Its price-to-book (P/B) ratio is 0.77.

What is the return on equity (ROE) of RMTI?

RMTI has a return on equity (ROE) of -14.37%. Its return on capital employed (ROCE) is -9.86%.

Is RMTI a good stock to buy?

This page provides a data-driven analysis of RMTI, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks

RMTI RMTI

Company Overview

Why Investors Should Care

Recent Developments

Growth & Price Performance

Compounded Sales Growth

Stock Price Performance

Price Chart

Technical Trend

Fundamental Growth Charts

PROS

CONS

Valuation

Growth (CAGR)

Profitability & Returns

Balance Sheet & Liquidity

Ownership

Financial Snapshot

Quarterly Results

Profit & Loss (Annual)

Balance Sheet (Annual)

Cash Flows (Annual)

Ratios (Annual)

Shareholding Pattern

Analyst View

Latest News

Rockwell Medical, Inc. (RMTI) stock price, news, quote and history - Yahoo Finance Australia

Rockwell Medical Shares Maintain $1 Bid, Nasdaq Matter Closed - Stock Titan

Rockwell Medical Announces First Reverse Stock Split In 4 Years – Nasdaq Compliance In Focus As Shares Haven’t Traded Above $1 Since March - Stocktwits

ROCKWELL MEDICAL ($RMTI) Releases Q4 2025 Earnings - Quiver Quantitative

Should Value Investors Buy Rockwell Medical (RMTI) Stock? - Yahoo Finance

What's Going On With Rockwell Medical Stock Wednesday? - Benzinga

RMTI — Frequently Asked Questions

What is the current share price of RMTI?

What is the market capitalisation of RMTI?

What is the P/E ratio of RMTI?

What is the return on equity (ROE) of RMTI?

Is RMTI a good stock to buy?

Explore More